GO
Loading...

Johnson & Johnson

More

  • Outlook: Investors Bracing For Big Earnings Week Friday, 12 Oct 2007 | 6:15 PM ET

    A slew of companies will be reporting third-quarter results, and investors will be watching not only for the latest figures but what companies predict about future profits.

  • Drugmakers Recall Infant Cold Products Thursday, 11 Oct 2007 | 12:16 PM ET

    Johnson & Johnson , Wyeth  and other makers of infants' nonprescription cough and cold products are recalling certain medicines in the United States because of the danger of overdose, the Consumer Healthcare Products Association said Thursday.

  • Medtronic: The Cents of Making Stents Thursday, 11 Oct 2007 | 10:42 AM ET

    Late yesterday an FDA panel of outside experts unanimously recommended the agency approve Medtronic's drug-coated stent called, "Endeavor". Unlike drugs, there is no telegraphed date for an agency decision, but analysts think the FDA will approve the device by the end of the year or early next year.

  • Your Health, Your Trade Wednesday, 10 Oct 2007 | 11:01 PM ET

    BREAKING: Reuters reports FDA panel backs drug-coated stents made by Medtronic (MDT).

  • Your First Move For Wednesday Oct. 10th Tuesday, 9 Oct 2007 | 9:19 PM ET

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Vanity Shares Monday, 8 Oct 2007 | 10:57 AM ET

    Companies that make us look good pretty up our wallets too.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • As recession fears recede, investors show an increasing willingness to bet on another interest rate cut from the Federal Reserve.

  • Your First Move For Wednesday Oct. 3rd Wednesday, 3 Oct 2007 | 11:12 AM ET

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Tylenol And The Thalidomide Scares: Moving Forward Tuesday, 2 Oct 2007 | 4:35 PM ET
    Old and new bottles of Tylenol products.

    This week it's 25 years since the first of seven people in Chicagoland died after taking Tylenol laced with cyanide. The scare led to new industry-standard, tamper-resistant over-the-counter drug packaging and became an enduring textbook case for corporate crisis management.

  • Pharmas Reaping Benefits of Weak Dollar Monday, 1 Oct 2007 | 3:18 PM ET

    The Dow is sitting at a new high and you could argue that the move in the pharmaceuticals sector today is largely market related with Dow components Merck, Pfizer and Johnson & Johnson all trading up. As I write this the biggest dollar gainer in the group is Eli Lilly. But the largest percentage gainer is Schering-Plough.

  • Stocks are likely to see further gains in the fourth quarter but the ride may be bumpy.  "October is usually volatile, but we may see a rally in November or December," says Charles Rotblut of Zacks.com.

  • Drugs On TV: My Review Of What's Playing Now Wednesday, 26 Sep 2007 | 8:55 AM ET

    A couple of days home sick with daytime television as your nursemaid can tell you a lot about the current state of multi-billion dollar pharmaceutical advertising. Yeah, we all know it's ubiquitous, but there are at least a couple of noticeable new players and an older one hitting the airwaves.

  • Promising Drug Headlines Tuesday, 25 Sep 2007 | 11:32 AM ET

    Look for pharmaceutical and biotech companies to make news this week as a UBS industry conference kicks off in New York. Also, Merrill Lynch analysts believe pricing power for prescription drugs is returning. What’s the trade?

  • Medicare: We Want Proof On Anemia Drugs Monday, 24 Sep 2007 | 2:56 PM ET

    Right on the heels of my previous blog entry about an analyst saying a Medicare reconsideration of its anemia drug reimbursement policy may be in the offing comes this news out of the agency.

  • Medicare Wants Proof for Amgen, J&J Anemia Drugs Monday, 24 Sep 2007 | 2:21 PM ET

    The U.S. Medicare agency said Monday that, unless it receives new evidence, it will not reverse a decision to cut payments for certain uses of anemia drugs, including Amgen's Aranesp.

  • Amgen: Getting a Second Chance From Medicare? Monday, 24 Sep 2007 | 11:37 AM ET

    After being down about half-a-dollar in early trading, volatile shares of Amgen are trimming their loses and heading back into positive territory at this writing. That turnaround could be from the dissemination of a research note from Wachovia biotech analyst George Farmer.

  • Millennium Drug Works as Initial Myeloma Therapy Tuesday, 18 Sep 2007 | 8:59 AM ET

    Millennium Pharmaceuticals said on Tuesday initial results from a large trial of its cancer drug Velcade as an initial treatment for multiple myeloma were so good that the trial was stopped early to allow patients in the control group to receive the therapy.

  • Fighting Diabetes and More Friday, 14 Sep 2007 | 12:30 PM ET

    Could a new pharmaceutical partnership be the best way to trade the rise in diabetes? In Thursday’s Web.Extra the traders reveal how to play the latest news. Also get their trades on hard drive behemoths Western Digital and Seagate.

  • Your First Move For Thursday Sept. 13th Thursday, 13 Sep 2007 | 3:41 PM ET

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Broken Baby Boomers Wednesday, 12 Sep 2007 | 8:36 PM ET

    In Wednesday’s Sea Change, Pete Najarian brings you a trade so good it will leave you weak in the knees.